Mode
Text Size
Log in / Sign up
N/A Completed N=128 Randomized Single-blind Treatment

POEM (Practice Of Embracing Each Moment) STUDY

Distress · Cancer · Chemotherapy Effect
Source: ClinicalTrials.gov NCT03078608 ↗
Enrolled (actual)
128
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcomePrimary: Change in Anxiety--patients — -1.4; -1.5 score on a scale — p=1.00

Summary

A cancer diagnosis is extremely stressful, emotionally challenging, and often life-altering for both patients and their loved ones. Although more than one-third of patients experience distress, doctors are typically at a loss as to how to help patients and their families manage these emotional challenges. Mindfulness-based programs, including meditation, are offered at major medical centers in the US and have been found to help reduce stress and improve quality of life among cancer patients. However, these classes often require 30+ hours of in-person instruction over 8 weeks, which is neither practical nor feasible for patients undergoing chemotherapy due to side effects and scheduling conflicts. This study will test whether an 8-week mobile app-based mindfulness program is accepted and useful for patients who have recently received chemotherapy and their loved ones. It will also test whether it is feasible to randomize participants into three groups: intervention, active control (receiving progressive muscle relaxation through the same app) and a wait list control group (will receive the meditation intervention 8 weeks later), so that a future study can test whether mindfulness intervention can help reduce stress and improve quality of life. Because many Americans own smartphone or tablet, an app that can teach stress reduction techniques at home or at infusion clinics has great potential to address emotional needs that providers often cannot. The study will also include caregivers of patients who have recently received chemotherapy as research has shown that caregivers tend to show high levels of stress and depression and worse physical health compared to non-caregivers. The negative effects of caregiving are most pronounced in caregivers of patients with cancer. However, little support is directed to caregivers as most medical attention goes toward the patients. The patient-caregiver relationship may serve as a source of mutual support and a surrogate for community, which is traditionally considered to be an essential ingredient for sustaining mindfulness practices. If this study is successful, it will justify a larger trial to determine if use of a mindfulness app is effective in reducing stress and improving quality of life for cancer patients and caregivers. If effective, this low-cost stress reduction strategy could be distributed and used for all types and stages of cancer patients and their caregivers, anywhere, any time, helping to improve the quality of life of the many individuals affected by cancer.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Anxiety--patients
-1.4; -1.5 1.00
PRIMARY
Change in Depression--patients
-1.2; 0 0.11
PRIMARY
Change in Anxiety--caregivers
-0.4; 0.3 0.79
PRIMARY
Change in Depression--caregivers
-1.2; -0.3 0.29
SECONDARY
Change in Distress--patients
-0.8; -0.5 0.67
SECONDARY
Change in Fatigue--patients
-0.8; 0 0.24
SECONDARY
Change in Pain Interference--patients
-2.2; 0.8 0.25
SECONDARY
Change in Distress--caregivers
-0.7; -0.2 0.47
SECONDARY
Change in Fatigue--caregivers
-0.8; -0.1 0.23
SECONDARY
Change in Pain Interference--caregivers
2.2; -0.4 0.39

Eligibility Criteria

Inclusion Criteria

  • active member of Kaiser Permanente Northern California
  • a diagnosis of cancer, and currently undergoing chemotherapy or completed chemotherapy in the past 6 months at time of recruitment
  • English literacy/fluency, access to a smartphone, a tablet (e.g., iPad) or a computer with internet
  • Caregivers: a partner, other family member, or a close friend who identify him/herself as the patient's primary unpaid caregiver. English literacy/fluency, access to a smartphone, a tablet (e.g., iPad) or a computer with internet access

Exclusion Criteria

  • Deafness
  • severe mental illness
  • Hospital Anxiety and Depression Scale score 14 on either anxiety or depression scale (patient only)
  • current stress reduction practice
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03078608). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search